Author:
Dantas Luiza Andraus,Pereira Marina Steingraber,Gauza Amanda de Miranda,Schulz Maria Eduarda Bonetti,Silva Gustavo Figueiredo da,Martin Maria Eduarda Marchi,Medeiros Junior Washigton Luiz Gomes de,Gonçalves Marcus Vinícius Magno
Subject
Clinical Neurology,Neurology,General Medicine
Reference21 articles.
1. Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting;Baldassari;Mult. Scler. J. Exp. Transl. Clin.,2019
2. Prevalence of latent tuberculosis (TB) in the multiple sclerosis (MS) clinic and effect of MS treatment on TB testing;Bouley;Int. J. MS Care,2020
3. Effect of teriflunomide on QuantiFERON-TB gold results;Bua;Med. Microbiol. Immunol.,2017
4. Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis;Buonomo;Expert Opin. Drug Saf.,2018
5. Progressive multiple sclerosis: from pathogenic mechanisms to treatment;Correale;Brain,2017
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献